ERBB2 and neoplasm: Farzad et al. fabricated Maleimide/PEG2000/DSPE nanoliposomes loaded with P435 HER2/neu-derived peptide that exhibited lower tumor size and a longer survival time in TUBO mice model, suggesting superior antitumor efficacy with good biocompatibility [57].